Teva Pharmaceuticals USA – Trademark Portfolio
Entity Type: 03
Teva Pharmaceuticals USA holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered and 8 are pending. Notable registered marks include SELARSDI. The owner is based in Parsippany, NJ.
400 Interpace Parkway
Building A
Parsippany, NJ 07054
Showing of trademarks Trademarks
Trademark Classifications
Teva Pharmaceuticals USA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Teva Pharmaceuticals USA have?
Teva Pharmaceuticals USA has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 pending, 2 abandoned, 1 cancelled.
What trademark classes does Teva Pharmaceuticals USA file in?
Teva Pharmaceuticals USA files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Teva Pharmaceuticals USA's most well-known trademarks?
Teva Pharmaceuticals USA's registered trademark portfolio includes well-known marks such as SELARSDI. These are among 1 currently registered trademark in the portfolio.
What is Teva Pharmaceuticals USA's trademark registration success rate?
Teva Pharmaceuticals USA has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 8 applications are pending review.